Regeneron Pharmaceuticals (REGN) EBT (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.36% |
| Dec 31, 2025 | -40.81% |
| Sep 30, 2025 | 16.11% |
| Jun 30, 2025 | 67.81% |
| Mar 31, 2025 | -5.54% |
| Dec 31, 2024 | -35.83% |
| Sep 30, 2024 | -8.30% |
| Jun 30, 2024 | 132.35% |
| Mar 31, 2024 | -38.94% |
| Dec 31, 2023 | 3.31% |
| Sep 30, 2023 | 2.58% |
| Jun 30, 2023 | 26.21% |
| Mar 31, 2023 | -35.23% |
| Dec 31, 2022 | -12.26% |
| Sep 30, 2022 | 56.75% |
| Jun 30, 2022 | -9.23% |
| Mar 31, 2022 | -57.61% |
| Dec 31, 2021 | 37.81% |
| Sep 30, 2021 | -51.59% |
| Jun 30, 2021 | 199.51% |
| Mar 31, 2021 | 2.32% |
| Dec 31, 2020 | 22.67% |
| Sep 30, 2020 | 8.64% |
| Jun 30, 2020 | 37.44% |
| Mar 31, 2020 | -24.86% |
| Dec 31, 2019 | 15.78% |
| Sep 30, 2019 | 242.01% |
| Jun 30, 2019 | -58.85% |
| Mar 31, 2019 | -19.24% |
| Dec 31, 2018 | 6.34% |
| Sep 30, 2018 | -3.08% |
| Jun 30, 2018 | 12.08% |
| Mar 31, 2018 | 5.52% |
| Dec 31, 2017 | -1.92% |
| Sep 30, 2017 | 7.56% |
| Jun 30, 2017 | 21.64% |
| Mar 31, 2017 | 26.58% |
| Dec 31, 2016 | -6.66% |
| Sep 30, 2016 | 25.19% |
| Jun 30, 2016 | -11.48% |
| Mar 31, 2016 | 45.26% |
| Dec 31, 2015 | -42.21% |
| Sep 30, 2015 | 19.91% |
| Jun 30, 2015 | 18.61% |
| Mar 31, 2015 | 976.07% |
| Dec 31, 2014 | -117.36% |
| Sep 30, 2014 | -12.92% |
| Jun 30, 2014 | 15.43% |
| Mar 31, 2014 | -0.16% |
| Dec 31, 2013 | -19.72% |
| Sep 30, 2013 | 52.81% |
| Jun 30, 2013 | 4.13% |
| Mar 31, 2013 | 5.40% |
| Dec 31, 2012 | -29.72% |
| Sep 30, 2012 | 149.49% |
| Jun 30, 2012 | 558.68% |
| Mar 31, 2012 | 121.55% |
| Dec 31, 2011 | 12.53% |
| Sep 30, 2011 | 2.47% |
| Jun 30, 2011 | -45.13% |
| Mar 31, 2011 | -199.12% |
| Dec 31, 2010 | 56.91% |
| Sep 30, 2010 | -32.98% |
| Jun 30, 2010 | 16.54% |
| Mar 31, 2010 | 24.84% |
| Dec 31, 2009 | -3,901.08% |
| Sep 30, 2009 | 93.21% |